Objectives: Icariin (ICA) is a bioactive flavonoid with renal protective actions. This study investigated the effects of ICA on renal injury, inflammation, oxidative damage, apoptosis, and survival in a mouse model of cecal ligation and perforation (CLP)-induced sepsis. Methods: Sepsis was induced by CLP. Mice were treated with ICA (30 or 60 mg/kg) for 3 days before CLP. Renal functions, inflammatory responses, oxidative damage, histological changes, apoptosis, and vascular permeability were examined. The effects of ICA on CLP-induced expression of renal nuclear factor-κB (NF-κB), cleaved caspase-3, Bax, and Bcl-2 were evaluated. Results: Mice in the CLP group had a low survival rate and increases in blood urea nitrogen and creatinine levels, proinflammatory cytokine levels, oxidative damage, apoptosis, and vascular permeability. These renal changes were dramatically improved by ICA treatment, especially in the 60 mg/kg ICA group. The detection of molecules involved in the inflammation and apoptosis of the kidney indicated that ICA reduced expression of NF-κB, cleaved caspase-3, and Bax but enhanced expression of Bcl-2. Conclusion: ICA improves CLP-induced mortality and acute kidney injury by inhibiting renal oxidant damage, inflammatory responses, apoptosis, and vascular permeability.

1.
Oh SJ, Kim JH, Chung DH: NOD2-mediated suppression of CD55 on neutrophils enhances C5a generation during polymicrobial sepsis. PLoS Pathog 2013; 9:e1003351.
2.
Ferrer R, Artigas A, Suarez D, Palencia E, Levy MM, Arenzana A, et al: Effectiveness of treatments for severe sepsis: a prospective, multicenter, observational study. Am J Respir Crit Care Med 2009; 180: 861–866.
3.
Murugan R, Kellum JA: Acute kidney injury: what's the prognosis? Nat Rev Nephrol 2011; 7: 209–217.
4.
Zarjou A, Agarwal A: Sepsis and acute kidney injury. J Am Soc Nephrol 2011; 22: 999–1006.
5.
Jackson WL Jr: Acute renal failure and sepsis. N Engl J Med 2004; 351: 2347–2349.
6.
Vincent JL, Opal SM, Marshall JC, Tracey KJ: Sepsis definitions: time for change. Lancet 2013; 381: 774–775.
7.
Cao YZ, Tu YY, Chen X, Wang BL, Zhong YX, Liu MH: Protective effect of Ulinastatin against murine models of sepsis: Inhibition of TNF-α and IL-6 and augmentation of IL-10 and IL-13. Exp Toxicol Pathol 2012; 64: 543–547.
8.
Faubel S, Lewis EC, Reznikov L, Ljubanovic D, Hoke TS, Somerset H, et al: Cisplatin-induced acute renal failure is associated with an increase in the cytokines interleukin (IL)-1beta, IL-18, IL-6, and neutrophil infiltration in the kidney. J Pharmacol Exp Ther 2007; 322: 8–15.
9.
Gill SE, Rohan M, Mehta S: Role of pulmonary microvascular endothelial cell apoptosis in murine sepsis-induced lung injury in vivo. Respir Res 2015; 16: 1–13.
10.
Kim YR, Hwang J, Koh HJ, Jang K, Lee JD, Choi J, et al: The targeted delivery of the c-Src peptide complexed with schizophyllan to macrophages inhibits polymicrobial sepsis and ulcerative colitis in mice. Biomaterials 2016; 89: 1–13.
11.
Li F, Gao B, Dong H, Shi J, Fang D: Icariin induces synoviolin expression through NFE2L1 to protect neurons from ER stress-induced apoptosis. PLoS One 2015; 10:e0119955.
12.
Havsteen BH: The biochemistry and medical significance of the flavonoids. Pharmacol Ther 2002; 96: 67–202.
13.
Zhang DW, Cheng Y, Wang NL, Zhang JC, Yang MS, Yao XS: Effects of total flavonoids and flavonol glycosides from Epimedium koreanum Nakai on the proliferation and differentiation of primary osteoblasts. Phytomedicine 2008; 15: 55–61.
14.
Wo YB, Zhu DY, Hu Y, Wang ZQ, Liu J, Lou YJ: Reactive oxygen species involved in prenylflavonoids, icariin and icaritin, initiating cardiac differentiation of mouse embryonic stem cells. J Cell Biochem 2008; 103: 1536–1550.
15.
Chen QP, Wei P: Icariin supplementation protects mice from exercise-induced oxidant stress in liver. Food Sci Biotechnol 2013; 22: 1409–1413.
16.
Chen KM, Ge BF, Liu XY, Ma PH, Lu MB, Bai MH, et al: Icariin inhibits the osteoclast formation induced by RANKL and macrophage-colony stimulating factor in mouse bone marrow culture. Pharmazie 2007; 62: 388–391.
17.
Zhang D, Zhang J, Fong C, Yao X, Yang M: Herba epimedii flavonoids suppress osteoclastic differentiation and bone resorption by inducing G2/M arrest and apoptosis. Biochimie 2012; 94: 2514–2522.
18.
Fan C, Yang Y, Liu Y, Jiang S, Di S, Hu W, et al: Icariin displays anticancer activity against human esophageal cancer cells via regulating endoplasmic reticulum stress-mediated apoptotic signaling. Sci Rep 2016; 6: 21145.
19.
Miyaji T, Hu X, Yuen PS, Muramatsu Y, Iyer S, Hewitt SM, et al: Ethyl pyruvate decreases sepsis-induced acute renal failure and multiple organ damage in aged mice. Kidney Int 2003; 64: 1620–1631.
20.
Rittirsch D, Huber-Lang MS, Flierl MA, Ward PA: Immunodesign of experimental sepsis by cecal ligation and puncture. Nat Protoc 2009; 4: 31–36.
21.
Ma P, Zhang S, Su X, Qiu G, Wu Z: Protective effects of icariin on cisplatin-induced acute renal injury in mice. Am J Transl Res 2015; 7: 2105–2114.
22.
Yasuda H, Yuen PS, Hu X, Zhou H, Star RA: Simvastatin improves sepsis-induced mortality and acute kidney injury via renal vascular effects. Kidney Int 2006; 69: 1535–1542.
23.
Qi S, Wu D: Bone marrow-derived mesenchymal stem cells protect against cisplatin-induced acute kidney injury in rats by inhibiting cell apoptosis. Int J Mol Med 2013; 32: 1262–1272.
24.
Huang XZ, Wen D, Zhang M, Xie Q, Ma L, Guan Y, et al: Sirt1 activation ameliorates renal fibrosis by inhibiting the TGF-β/Smad3 pathway. J Cell Biochem 2014; 115: 996–1005.
25.
Xu CQ, Liu BJ, Wu JF, Xu YC, Duan XH, Cao YX, et al: Icariin attenuates LPS-induced acute inflammatory responses: involvement of PI3K/Akt and NF-kappaB signaling pathway. Eur J Pharmacol 2010; 642: 146–153.
26.
Cui R, Chen X, Peng L, Ma J, Zhu D, Li T, et al: Multiple mechanisms in renal artery stenosis-induced renal interstitial fibrosis. Nephron Exp Nephrol 2014; 128: 57–66.
27.
Cruz D, Geus HR, Ronco C, Groeneveld AB, Kulkarni OP, Hagemann JH, et al: New advances in the pathophysology of AKI. Nephrol Dial Transpl 2017; 6: 247–251.
28.
Lee SY, Lee YS, Choi HM, Ko YS, Lee HY, Jo SK, et al: Distinct pathophysiologic mechanisms of septic acute kidney injury: role of immune suppression and renal tubular cell apoptosis in murine model of septic acute kidney injury. Crit Care Med 2012; 40: 2997–3006.
29.
Baradaran A, Nasri H, Rafieian-Kopaei M: Protection of renal tubular cells by antioxidants: current knowledge and new trends. Cell J 2015; 16: 568–571.
30.
Nasri H, Rafieian-Kopaei M: Protective effects of herbal antioxidants on diabetic kidney disease. J Res Med Sci 2014; 19: 82–83.
31.
Baradaran A, Nasri H, Nematbakhsh M, Rafieian-Kopaei M: Antioxidant activity and preventive effect of aqueous leaf extract of Aloe Vera on gentamicin-induced nephrotoxicity in male Wistar rats. Clin Ter 2014; 165: 7–11.
32.
Nasri H, Rafieiankopaei M: Tubular kidney protection by antioxidants. Iranian J Public Health 2013; 42: 1194–1196.
33.
Liang SR, Bi JW, Guo ZL, Bai Y, Hu Z: Protective effect of icariin on kidney in 5/6 nephrectomized rats and its mechanism. Genet Mol Res 2014; 13: 6466–6471.
34.
Deng D, Li X, Liu C, Zhai Z, Li B, Kuang M , et al: Systematic investigation on the turning point of over-inflammation to immunosuppression in CLP mice model and their characteristics. Int Immunopharmacol 2017; 42: 49–58.
35.
Cohen J: The immunopathogenesis of sepsis. Nature 2002: 885–891.
36.
Mihai MM, Tranca S, Dîrzu D, Hutanu A, Platon O, Dobreanu D: Comparing the anti-inflammatory effects of Simvastatin and Rosuvastatin by measuring IL-1β, IL-6 and TNF-α levels using a murinic caecal ligation and puncture induced sepsis model. Rom Rev Lab Med 2014; 22: 439–450.
37.
Gül M, Ayan M, Seydanoglu A, Cander B, Girisgin S, Erayman I, et al: The effect of N-acetyl cysteine on serum glutathione, TNF-alpha and tissue malondialdehyde levels in the treatment of sepsis. Ulus Travma Acil Cerrahi Derg 2011; 17: 293–297.
38.
Riedemann NC, Neff TA, Guo RF, Bernacki KD, Laudes IJ, Sarma JV, et al: Protective effects of IL-6 blockade in sepsis are linked to reduced C5a receptor expression. J Immunol 2003; 170: 503–507.
39.
Singleton KD, Wischmeyer PE: Glutamine attenuates inflammation and NF-κB activation via Cullin-1 deneddylation. Biochem Biophys Res Commun 2008; 373: 445–449.
40.
Li L, Sun J, Xu C, Zhang H, Wu J, Liu B, et al: Icariin ameliorates cigarette smoke induced inflammatory responses via suppression of NF-κB and modulation of GR in vivo and in vitro. PLoS One 2014; 9:e102345.
41.
Ware LB, Fessel JP, May AK, Roberts LJ 2nd: Plasma biomarkers of oxidant stress and development of organ failure in severe sepsis. Shock 2011; 36: 12–17.
42.
Levent G, Ali A, Ahmet A, Polat EC, Aytaç C, Ayse E, et al: Oxidative stress and antioxidant defense in patients with chronic hepatitis C patients before and after pegylated interferon alfa-2b plus ribavirin therapy. J Transl Med 2006; 4: 25.
43.
Rafieian-Kopaei M, Shahinfard N, Rouhi-Boroujeni H, Gharipour M, Darvishzadeh-Boroujeni P: Effects of ferulago angulata extract on serum lipids and lipid peroxidation. Evid Based Complement Alternat Med 2014; 2014: 680856.
44.
Xiong W, Chen Y, Wang Y, Liu J: Roles of the antioxidant properties of icariin and its phosphorylated derivative in the protection against duck virus hepatitis. BMC Vet Res 2014; 10: 226.
45.
Reséndiz-Martínez J, Asbun-Bojalil J, Huerta-Yepez S, Vega M: Correlation of the expression of YY1 and Fas cell surface death receptor with apoptosis of peripheral blood mononuclear cells, and the development of multiple organ dysfunction in children with sepsis. Mol Med Rep 2017; 15: 2433–2442.
46.
Koçkara A, Kayatas M: Renal cell apoptosis and new treatment options in sepsis-induced acute kidney injury. Ren Fail 2013; 35: 291–294.
47.
Wang Z, Holthoff JH, Seely KA, Pathak E, Spencer HJ 3rd, Gokden N, Mayeux PR: Development of oxidative stress in the peritubular capillary microenvironment mediates sepsis-induced renal microcirculatory failure and acute kidney injury. Am J Pathol 2012; 180: 505–516.
48.
Wang Z, Sims CR, Patil NK, Gokden N, Mayeux PR: Pharmacologic targeting of sphingosine-1-phosphate receptor 1 improves the renal microcirculation during sepsis in the mouse. J Pharmacol Exp Ther 2015; 352: 61–66.
49.
Kramann R, Tanaka M, Humphreys BD: Fluorescence microangiography for quantitative assessment of peritubular capillary changes after AKI in mice. J Am Soc Nephrol 2014; 25: 1924–1931.
50.
Goldenberg NM, Steinberg BE, Slutsky AS, Lee WL: Broken barriers: a new take on sepsis pathogenesis. Sci Transl Med 2011; 3: 88ps25.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.